Brief: Todos Medical Completes Trial Design For Tollovid Long Covid Clinical Study In Adults
11/08/2022 14:08
Aug 11 (Reuters) - Todos Medical Ltd TOMDF.PK :
* TODOS MEDICAL COMPLETES TRIAL DESIGN FOR TOLLOVID™ LONG
COVID
CLINICAL STUDY IN ADULTS
* TODOS MEDICAL LTD - COMPANY EXPECTS PART A OF STUDY TO
COMPLETE
IN Q4 OF 2022
Source text for Eikon: ID:nGNX5HCjYZ
Further company coverage: TOMDF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities